22 related articles for article (PubMed ID: 8920779)
1. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.
Kallinowski B; Haseroth K; Marinos G; Hanck C; Stremmel W; Theilmann L; Singer MV; Rossol S
Clin Exp Immunol; 1998 Feb; 111(2):269-77. PubMed ID: 9486392
[TBL] [Abstract][Full Text] [Related]
2. Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.
Landmann R; Keilholz U; Scheibenbogen C; Brockhaus M; Gallati H; Denz H; Bargetzi M; Ludwig C
Cancer Immunol Immunother; 1994 Feb; 38(2):113-8. PubMed ID: 8306366
[TBL] [Abstract][Full Text] [Related]
3. The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy.
Takahashi H; Yoshimatsu G; Faustman DL
Cells; 2022 Jun; 11(12):. PubMed ID: 35741080
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I.
Selinsky CL; Boroughs KL; Halsey WA; Howell MD
Immunology; 1998 May; 94(1):88-93. PubMed ID: 9708191
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Gagetti O; Prontera C; Bianchi R; Facchini V
Gynecol Oncol; 1995 Aug; 58(2):184-8. PubMed ID: 7542621
[TBL] [Abstract][Full Text] [Related]
6. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in patients with cervical cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prontera C; Facchini V; Genazzani A
Oncol Rep; 1996 Sep; 3(5):891-4. PubMed ID: 21594476
[TBL] [Abstract][Full Text] [Related]
9. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
Zhou J; Zhao Q; Yao H
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):158-60. PubMed ID: 11778489
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prato B; Prontera C; Facchini V; Genazzani AR
Anticancer Res; 1996; 16(5B):3125-8. PubMed ID: 8920779
[TBL] [Abstract][Full Text] [Related]
11. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
Modzelewski B
Pol Merkur Lekarski; 2003 Jan; 14(79):69-72. PubMed ID: 12712835
[TBL] [Abstract][Full Text] [Related]
12. Soluble cytokine receptors: novel immunotherapeutic agents.
Fernandez-Botran R
Expert Opin Investig Drugs; 2000 Mar; 9(3):497-514. PubMed ID: 11060691
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
